Review on Targeted Drug Delivery System
Background: Targeted drug delivery systems (TDDSs) are revolutionary systems that improve the efficacy and safety of therapeutic agents in the field of pharmaceutical science. The goal of these systems is to enable drug delivery only to the target site in the body where it is required thus enhancing therapeutic outcomes while avoiding unwanted systemic side effects. Action Mechanisms: TDDSs facilitate site-specific drug release through different mechanisms such as bioconjugation and the utilization of nanoparticle technology. On the one hand, folate-targeted delivery takes advantage of the overexpression of folate receptors on cancer cells to increase internalization of the therapeutic agents. Moreover, TDDSs can also be designed to respond to certain stimuli, such as pH, temperature, or even enzymatic activity, allowing for controlled and prolonged drug liberation. Advantages Over Conventional Systems: TDDSs present certain benefits over conventional systems with the advantages of decreasing toxicity, enhancing bioavailability, and increasing patient compliance. These systems enhance the therapeutic index and reduce dosing frequency by minimizing unwanted off-target effects while maximizing drug concentration at the on-target site. Challenges and Future Directions: TDDS methodologies will likely lead to breakthroughs in drug delivery and therapy, opening up new opportunities in the healthcare domain. Current efforts are aimed at optimizing nanocarriers, employing intelligent delivery strategies, and enhancing personalized medicine approaches. Innovations in TDDSs have the potential to extend the application of TDDSs into diverse therapeutic areas, ranging from cancer therapy to vaccine development and gene delivery. Conclusion: The persistent progress of TDDSs is revolutionizing the modern medicine, providing more safe, effective, and highly specific therapeutic strategies for a diversity of diseases.
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-03-04
- DOI
- https://doi.org/10.5281/zenodo.14964795
- Primary Topic
- Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00